Effect of Dapagliflozin on the Risk of New-onset Atrial Fibrillation during Hospitalization for Acute Myocardial Infarction in Patients with Type 2 Diabetes

Effect of Dapagliflozin on the Risk of New-onset Atrial Fibrillation during Hospitalization for Acute Myocardial Infarction in Patients with Type 2 Diabetes

BackgroundAtrial fibrillation is a common complication of acute myocardial infarction with an incidence varying from 5% to 20%. New-onset atrial fibrillation developing after acute myocardial fibrillation indicates a significantly increased risk of death and stroke. Diabetes mellitus, as a shared ri...

Full description

Bibliographic Details
Main Author: ZHENG Rujie, WANG Yue, JIANG Yaohui, ZHANG Jinying
Format: Article
Language:zho
Published: Chinese General Practice Publishing House Co., Ltd 2022-02-01
Series:Zhongguo quanke yixue
Subjects:
|diabetes mellitus, type 2|dapagliflozin|myocardial infarction|atrial fibrillation|hospitalization|risk reduction behavior|root cause analysis
Online Access:https://www.chinagp.net/fileup/1007-9572/PDF/1643428285535-1056172870.pdf

Similar Items

Similar Items